<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> brain damage-cerebrovascular or cardiovascular, traumatic or infectious-released brain-type isoenzyme of <z:chebi fb="2" ids="16919">creatine</z:chebi> kinase (BB-CK) into the circulation within a few hours in 16 of 62 patients (26%) </plain></SENT>
<SENT sid="1" pm="."><plain>Occurrence of BB-CK was transient in the serum </plain></SENT>
<SENT sid="2" pm="."><plain>BB-CK activity was found in the peripheral blood in 13 of 23 patients with diffuse brain damage compared to three of 39 patients with a local <z:hpo ids='HP_0001297'>cerebrovascular accident</z:hpo> (P less than .0005) </plain></SENT>
<SENT sid="3" pm="."><plain>The mortality of patients having BB-CK in their serum was 63% compared to 39% of those without BB-CK activity in their serum (P less than .05) </plain></SENT>
</text></document>